EMA gives thumbs up to Vanda sleep disorder drug; Zynga names ex-Genentech CFO to its board;

@FiercePharma: Labeling foul-up involving acetaminophen leads RB to recall 135 lots of Mucinex. News | Follow @FiercePharma

@EricPFierce: Bayer to close a vet med plant in Missouri it bought from Teva. 130 workers to lose jobs. Article | Follow @EricPFierce

@CarlyHFierce: ICYMI: Watch out, Big Pharma: A Teva-Mylan combo would remake the industry Top 10. Story | Follow @CarlyHFierce

> Vanda Pharmaceuticals ($VNDA) drug Helioz has been recommended for approval in Europe to treat non-24-hour sleep-wake disorder in totally blind adults. Release

> The European Medicines Agency, like the FDA, has found there is a risk of severe bradycardia or heart block problems when Gilead Sciences' ($GILD) hep C combo drug Harvoni is taken by patients who also are on amiodarone for treating an irregular heartbeat. Release

> Mobile game maker Zynga has added former Genetech CFO Louis Lavigne to its board. Release

Medical Device News

@FierceMedDev: Low-cost smart syringe shoots for reduced disease transmission. News | Follow @FierceMedDev

@VarunSaxena2: Ahead of Apple Watch launch, hearing aid company reveals its app development experience. Story | Follow @VarunSaxena2

@EmilyWFierce: Medical device makers such as $GE, $ABT, $BSX and $JNJ forming the first industry trade group in #Asia. Pharmalot story | Follow @EmilyWFierce

> Bard's Lutonix drug-coated balloons help lift Q1 earnings. News

> FDA deems all 4,000+ of troubled Maquet's left atrial appendage closure devices potentially deadly, announces major recall. More

Biotech News

@FierceBiotech: AstraZeneca loans its oncology star to Celgene, recruits Innate in a PD-L1 deal spree. News | Follow @FierceBiotech

@JohnCFierce: Aerie shares crushed after glaucoma therapy flops in PhIII. Story | Follow @JohnCFierce

> Biogen blueprints a big Phase III effort for its Alzheimer's hopeful. Article

> Regeneron, Alnylam help drive a $2B spike in biotech R&D spending. More

> Sanofi dumps an ImmunoGen cancer drug as it scales back in oncology. News

Suggested Articles

Amid Amgen's pricing war with Sanofi and Regeneron's Praluent, PCSK9 cholesterol fighter Repatha has shown a clinical benefit for HIV patients.

A month after the FDA approved it, Esperion's Nexletol showed it can lower cholesterol regardless of statin and ezitimibe treatment.

AstraZeneca's Farxiga can help prevent worsening or death in heart failure patients regardless of other therapies received, according to new data.